Presence of M. leprae in tissues in slit skin smear negative multibacillary (MB) patients after WHO-MBR

Leprosy Review

Volumn 70, Issue 3, 1999, Pages 281-286

  Sharma, Anupma ^a   Sharma, Vinod Kumar ^a,b   Rajwanshi, Arvind ^a   Das, Ashim ^a   Kaur, Inderjeet ^a   Kumar, Bhushan ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ERADICATION THERAPY; ERYTHEMA; FEMALE; HUMAN; LEPROSY; LYMPH NODE; MONOTHERAPY; MYCOBACTERIUM LEPRAE; NERVE BIOPSY; SKIN BIOPSY; WORLD HEALTH ORGANIZATION;

EID: 0033376182     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: 10.5935/0305-7518.19990031     Document Type: Article

References (15)

1. Water MFR, Rees RJW, McDougall AC, Weddell AGM. Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histopathological assessment and the finding of viable bacilli. Lepr Rev, 1974; 45: 288-298.
2. Ramu G, Desikan KV. A study of scrotal biopsy in subsided cases of lepromatous leprosy. Leprosy in India, 1979; 51: 341-347.
3. Toman K. Bacterial persistance in leprosy. Int J Lepr, 1981; 47: 205-217.
4. WHO technical report series-847, WHO study group on chemotherapy of leprosy. WHO 1994.
5. Kaur, Kumar B, Gupta K. Fine needle aspiration of lymph nodes in leprosy. A study of bacteriologic and morphologic indices. Int J Lepr, 1973; 41: 94-101.
6. Kaur S, Sharma VK, Basak P, Kaur Radotra BD. Concurrent skin and nerve histology in leprosy. Lepr Rev, 1993; 64: 110-116.
7. Job CK. Histopathological features of relapsed leprosy. Ind J Lepr, 1995; 67: 69-80.
8. Marchoux Chemotherapy Study Group. Relapses in multibacillary leprosy patients after stopping treatment with riframpin-containing combined regimens. Ind J Lepr, 1992; 60: 525-535.
9. Katoch K, Ramu G, Ramanthan US, Sharma VD, Shivannavar CT, Katoch VM. Results of a modified WHO regimen in highly bacilliferous BL/LL patients. Int J Lepr, 1989; 57: 451-457.
10. Shetty VP, Suchitra K, Uplekar MW, Antia NH. Higher incidence of viable Mycobacterium leprae within the nerve as compared to skin among multibacillary leprosy patients released from multi-drug therapy. Int J Lepr, 1997; 68: 131-138.
11. Shetty V, Naik SM, Uplekar M, Antia NM. Lepra viability in skin and nerve after MDT and their sensitivity to a anti-leprosy drugs. Int J Lepr, 1993; 61: 4-A.
12. Job CK, Jayakumar J, Aschoff M, Nathan MM. Viability of Myobacterium leprae in skin and perpheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy. Int J Lepr, 1996; 64: 44-50.
13. Sivaprasad N, Snehalatha S, Lobo D, Aschoff M, Job CK. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy with two years of multidrug therapy. Ind J Lepr, 1995; 67: 427-433.
14. Karat ABA, Jamuet I, Albert R, Kumar ASJ. Experiments in cultivation of M. leprae in monkeys and footpads of mice - an interim report of six years of study. Leprosy in India, 1973; 45: 138.
15. Pattyn SR, Bourland S, Grillone G, Ghys P. Combined regimens of one year duration in the treatment of multibacillary leprosy I. Combined regimen with rifampicin administered during one year. Lepr Rev, 1989; 60: 109-118.